DIVIS LABORATORIES
Back to Cashflow Statement
|
DIVIS LABORATORIES Last 5 Year Cash Flow from Investing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Investing Activities | ₹-804 Cr | ₹-269 Cr | ₹-2,707 Cr | ₹-2,195 Cr | ₹75 Cr |
What is the latest Cash Flow from Investing Activities ratio of DIVIS LABORATORIES ?
| Year | Cash Flow from Investing Activities |
|---|---|
| Mar2025 | ₹-804 Cr |
| Mar2024 | ₹-269 Cr |
| Mar2023 | ₹-2,707 Cr |
| Mar2022 | ₹-2,195 Cr |
| Mar2021 | ₹75 Cr |
How is Cash Flow from Investing Activities of DIVIS LABORATORIES Trending?
| Years | Cash Flow from Investing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-804 Cr | Negative | |
| Mar2024 | ₹-269 Cr | Negative | |
| Mar2023 | ₹-2,707 Cr | Negative | |
| Mar2022 | ₹-2,195 Cr | Negative | |
| Mar2021 | ₹75 Cr | - | |
Compare Cash Flow from Investing Activities of peers of DIVIS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DIVIS LABORATORIES | ₹161,554.1 Cr | -4.2% | -1.4% | 9.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹430,825.0 Cr | -1.6% | 5.7% | 7.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹145,733.0 Cr | -2.8% | 5.7% | 39.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,094.0 Cr | -3.2% | 1.2% | 14.2% | Stock Analytics | |
| CIPLA | ₹103,513.0 Cr | -3.6% | -3.7% | -10.2% | Stock Analytics | |
| MANKIND PHARMA | ₹85,350.2 Cr | -7.9% | 0.4% | -5.4% | Stock Analytics | |
DIVIS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DIVIS LABORATORIES | -4.2% |
-1.4% |
9.6% |
| SENSEX | -2.7% |
-9.1% |
2.6% |
You may also like the below Video Courses